Literature DB >> 32338224

Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective.

Thea Magrone1, Manrico Magrone1, Emilio Jirillo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32338224     DOI： 10.2174/1871530320666200427112902

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN： 1871-5303            Impact factor:   2.895


× No keyword cloud information.
  67 in total

Review 1.  Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection.

Authors:  Rossella Talotta; Erle S Roberston
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

Review 2.  Neurobiology of COVID-19.

Authors:  Majid Fotuhi; Ali Mian; Somayeh Meysami; Cyrus A Raji
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19.

Authors:  Pradeep Singh Cheema; Deeptashree Nandi; Alo Nag
Journal:  Open Biol       Date:  2021-06-09       Impact factor: 6.411

4.  Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?

Authors:  Ramachandran Vignesh; Vijayakumar Velu; Sripathi M Sureban
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

Review 5.  SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models.

Authors:  G Kanimozhi; B Pradhapsingh; Charan Singh Pawar; Haseeb A Khan; Salman H Alrokayan; N Rajendra Prasad
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.

Authors:  Shibi Muralidar; Gayathri Gopal; Senthil Visaga Ambi
Journal:  J Med Virol       Date:  2021-05-03       Impact factor: 20.693

Review 7.  Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.

Authors:  Domenico Nuzzo; Sonya Vasto; Luca Scalisi; Salvatore Cottone; Gaetano Cambula; Manfredi Rizzo; Daniela Giacomazza; Pasquale Picone
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

8.  Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.

Authors:  Adrian Rice; Mohit Verma; Annie Shin; Lise Zakin; Peter Sieling; Shiho Tanaka; Joseph Balint; Kyle Dinkins; Helty Adisetiyo; Brett Morimoto; Wendy Higashide; C Anders Olson; Shivani Mody; Patricia Spilman; Elizabeth Gabitzsch; Jeffrey T Safrit; Shahrooz Rabizadeh; Kayvan Niazi; Patrick Soon-Shiong
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

Review 9.  A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.

Authors:  Elizabeth M Sajdel-Sulkowska
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

10.  Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.

Authors:  Francesca Lunardi; Francesco Fortarezza; Luca Vedovelli; Federica Pezzuto; Annalisa Boscolo; Marco Rossato; Roberto Vettor; Anna Maria Cattelan; Claudia Del Vecchio; Andrea Crisanti; Paolo Navalesi; Dario Gregori; Fiorella Calabrese
Journal:  Biomolecules       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.